Which has higher valuation and earnings, SNWV or OWLT?

Sanuwave Health has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sanuwave Health $44.05M 0.87 $11.81M $0.24 18.54 Owlet $105.70M 1.39 -$39.68M -$0.75 N/A

Is SNWV or OWLT more profitable?

Sanuwave Health has a net margin of 32.38% compared to Owlet's net margin of -8.61%. Sanuwave Health's return on equity of 1,728.10% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Sanuwave Health 32.38% 1,728.10% 39.04% Owlet -8.61% -601.24% -15.96%

Do analysts recommend SNWV or HSAQ?

Sanuwave Health presently has a consensus target price of $47.00, indicating a potential upside of 956.18%. Given Sanuwave Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Sanuwave Health is more favorable than Health Sciences Acquisitions Co. 2. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanuwave Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Health Sciences Acquisitions Co. 2 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings & valuation, SNWV or HSAQ?

Sanuwave Health has higher revenue and earnings than Health Sciences Acquisitions Co. 2. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sanuwave Health $44.05M 0.87 $11.81M $0.24 18.54 Health Sciences Acquisitions Co. 2 N/A N/A -$380K N/A N/A

Do analysts rate INGN or SNWV?

Sanuwave Health has a consensus price target of $47.00, indicating a potential upside of 956.18%. Given Sanuwave Health's higher probable upside, analysts plainly believe Sanuwave Health is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Sanuwave Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is INGN or SNWV more profitable?

Sanuwave Health has a net margin of 32.38% compared to Inogen's net margin of -6.94%. Sanuwave Health's return on equity of 1,728.10% beat Inogen's return on equity. Company Net Margins Return on Equity Return on Assets Inogen -6.94% -13.17% -8.36% Sanuwave Health 32.38% 1,728.10% 39.04%

Sanuwave Health (SNWV) Competitors

$4.45 0.00 (0.00%)

As of 09/3/2026 04:00 PM Eastern

Compare

SNWV vs. FOCL, OWLT, HSAQ, INGN, and KRMD

Should you buy Sanuwave Health stock or one of its competitors? Sanuwave Health's main competitors and comparable companies include FocalTherics (FOCL), Owlet (OWLT), Health Sciences Acquisitions Co. 2 (HSAQ), Inogen (INGN), and KORU Medical Systems (KRMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sanuwave Health compare to FocalTherics?

Sanuwave Health (NASDAQ:SNWV) and FocalTherics (NASDAQ:FOCL) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, profitability, risk, dividends, earnings and analyst recommendations.

Sanuwave Health presently has a consensus target price of $47.00, indicating a potential upside of 956.18%. FocalTherics has a consensus target price of $7.75, indicating a potential upside of 85.85%. Given Sanuwave Health's higher probable upside, analysts clearly believe Sanuwave Health is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

Sanuwave Health has higher earnings, but lower revenue than FocalTherics. FocalTherics is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	0.87	$11.81M	$0.24	18.54
FocalTherics	$70.53M	2.22	-$29.25M	-$1.03	N/A

Sanuwave Health has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market. Comparatively, FocalTherics has a beta of -0.07, suggesting that its share price is 107% less volatile than the broader market.

Sanuwave Health has a net margin of 32.38% compared to FocalTherics' net margin of -56.26%. Sanuwave Health's return on equity of 1,728.10% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	32.38%	1,728.10%	39.04%
FocalTherics	-56.26%	-248.00%	-44.69%

In the previous week, FocalTherics had 2 more articles in the media than Sanuwave Health. MarketBeat recorded 2 mentions for FocalTherics and 0 mentions for Sanuwave Health. FocalTherics' average media sentiment score of 0.67 beat Sanuwave Health's score of 0.00 indicating that FocalTherics is being referred to more favorably in the news media.

Company	Overall Sentiment
Sanuwave Health	Neutral
FocalTherics	Positive

42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 62.7% of FocalTherics shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by insiders. Comparatively, 10.1% of FocalTherics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Sanuwave Health beats FocalTherics on 9 of the 16 factors compared between the two stocks.

How does Sanuwave Health compare to Owlet?

Sanuwave Health (NASDAQ:SNWV) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

In the previous week, Sanuwave Health's average media sentiment score of 0.00 equaled Owlet'saverage media sentiment score.

Company	Overall Sentiment
Sanuwave Health	Neutral
Owlet	Neutral

Sanuwave Health has a net margin of 32.38% compared to Owlet's net margin of -8.61%. Sanuwave Health's return on equity of 1,728.10% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	32.38%	1,728.10%	39.04%
Owlet	-8.61%	-601.24%	-15.96%

Sanuwave Health currently has a consensus price target of $47.00, indicating a potential upside of 956.18%. Owlet has a consensus price target of $15.00, indicating a potential upside of 198.80%. Given Sanuwave Health's higher possible upside, equities analysts plainly believe Sanuwave Health is more favorable than Owlet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by insiders. Comparatively, 36.2% of Owlet shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Sanuwave Health has a beta of 1.47, meaning that its share price is 47% more volatile than the broader market. Comparatively, Owlet has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market.

Sanuwave Health has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	0.87	$11.81M	$0.24	18.54
Owlet	$105.70M	1.39	-$39.68M	-$0.75	N/A

Summary

Sanuwave Health and Owlet tied by winning 7 of the 14 factors compared between the two stocks.

How does Sanuwave Health compare to Health Sciences Acquisitions Co. 2?

Sanuwave Health (NASDAQ:SNWV) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

Sanuwave Health has a beta of 1.47, meaning that its stock price is 47% more volatile than the broader market. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its stock price is 91% less volatile than the broader market.

Sanuwave Health presently has a consensus target price of $47.00, indicating a potential upside of 956.18%. Given Sanuwave Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Sanuwave Health is more favorable than Health Sciences Acquisitions Co. 2.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Health Sciences Acquisitions Co. 2	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by company insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Sanuwave Health's average media sentiment score of 0.00 equaled Health Sciences Acquisitions Co. 2'saverage media sentiment score.

Company	Overall Sentiment
Sanuwave Health	Neutral
Health Sciences Acquisitions Co. 2	Neutral

Sanuwave Health has a net margin of 32.38% compared to Health Sciences Acquisitions Co. 2's net margin of 0.00%. Sanuwave Health's return on equity of 1,728.10% beat Health Sciences Acquisitions Co. 2's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	32.38%	1,728.10%	39.04%
Health Sciences Acquisitions Co. 2	N/A	N/A	-2.38%

Sanuwave Health has higher revenue and earnings than Health Sciences Acquisitions Co. 2.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	0.87	$11.81M	$0.24	18.54
Health Sciences Acquisitions Co. 2	N/A	N/A	-$380K	N/A	N/A

Summary

Sanuwave Health beats Health Sciences Acquisitions Co. 2 on 9 of the 11 factors compared between the two stocks.

How does Sanuwave Health compare to Inogen?

Inogen (NASDAQ:INGN) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

In the previous week, Inogen had 1 more articles in the media than Sanuwave Health. MarketBeat recorded 1 mentions for Inogen and 0 mentions for Sanuwave Health. Inogen's average media sentiment score of 0.59 beat Sanuwave Health's score of 0.00 indicating that Inogen is being referred to more favorably in the media.

Company	Overall Sentiment
Inogen	Positive
Sanuwave Health	Neutral

Sanuwave Health has a net margin of 32.38% compared to Inogen's net margin of -6.94%. Sanuwave Health's return on equity of 1,728.10% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-6.94%	-13.17%	-8.36%
Sanuwave Health	32.38%	1,728.10%	39.04%

Inogen has a beta of 1.57, suggesting that its stock price is 57% more volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market.

Sanuwave Health has a consensus price target of $47.00, indicating a potential upside of 956.18%. Given Sanuwave Health's higher probable upside, analysts plainly believe Sanuwave Health is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

89.9% of Inogen shares are held by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are held by institutional investors. 2.5% of Inogen shares are held by insiders. Comparatively, 14.4% of Sanuwave Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Sanuwave Health has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$348.67M	0.41	-$22.75M	-$0.90	N/A
Sanuwave Health	$44.05M	0.87	$11.81M	$0.24	18.54

Summary

Sanuwave Health beats Inogen on 10 of the 17 factors compared between the two stocks.

How does Sanuwave Health compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

Sanuwave Health has a net margin of 32.38% compared to KORU Medical Systems' net margin of -4.03%. Sanuwave Health's return on equity of 1,728.10% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Sanuwave Health	32.38%	1,728.10%	39.04%

Sanuwave Health has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.60	-$2.64M	-$0.04	N/A
Sanuwave Health	$44.05M	0.87	$11.81M	$0.24	18.54

KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market.

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by insiders. Comparatively, 14.4% of Sanuwave Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

KORU Medical Systems currently has a consensus target price of $7.00, indicating a potential upside of 117.39%. Sanuwave Health has a consensus target price of $47.00, indicating a potential upside of 956.18%. Given Sanuwave Health's higher possible upside, analysts clearly believe Sanuwave Health is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, KORU Medical Systems had 1 more articles in the media than Sanuwave Health. MarketBeat recorded 1 mentions for KORU Medical Systems and 0 mentions for Sanuwave Health. KORU Medical Systems' average media sentiment score of 0.00 equaled Sanuwave Health'saverage media sentiment score.

Company	Overall Sentiment
KORU Medical Systems	Neutral
Sanuwave Health	Neutral

Summary

Sanuwave Health beats KORU Medical Systems on 9 of the 15 factors compared between the two stocks.

Get Sanuwave Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SNWV vs. The Competition

Export

Metric	Sanuwave Health	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$38.26M	$5.81B	$7.26B	$12.73B
Dividend Yield	N/A	1.76%	2.53%	8.86%
P/E Ratio	18.54	25.92	273.29	25.38
Price / Sales	0.87	73.28	613.45	92.55
Price / Cash	2.62	33.14	77.82	52.26
Price / Book	13.91	6.04	12.89	6.14
Net Income	$11.81M	$150.03M	$3.47B	$349.01M
7 Day Performance	-4.91%	-1.32%	0.60%	-0.27%
1 Month Performance	-26.57%	1.27%	5.73%	0.68%
1 Year Performance	-88.48%	9.88%	25.35%	14.84%

Sanuwave Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
SNWV Sanuwave Health	2.7205 of 5 stars	$4.45 flat	$47.00 +956.2%	-88.5%	$38.26M	$44.05M	18.54	40
FOCL FocalTherics	4.3387 of 5 stars	$4.13 -2.6%	$7.75 +87.7%	N/A	$154.80M	$70.53M	N/A	230
OWLT Owlet	2.3523 of 5 stars	$5.23 -6.3%	$15.00 +186.8%	-32.2%	$151.95M	$105.70M	N/A	106
HSAQ Health Sciences Acquisitions Co. 2	N/A	$5.36 -1.3%	N/A	+80.7%	$149.23M	N/A	N/A	4
INGN Inogen	0.7689 of 5 stars	$5.61 +0.2%	N/A	-30.8%	$148.88M	$348.67M	N/A	1,030

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SNWV) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sanuwave Health (SNWV) Competitors

SNWV vs. FOCL, OWLT, HSAQ, INGN, and KRMD

How does Sanuwave Health compare to FocalTherics?

Summary

How does Sanuwave Health compare to Owlet?

Summary

How does Sanuwave Health compare to Health Sciences Acquisitions Co. 2?

Summary

How does Sanuwave Health compare to Inogen?

Summary

How does Sanuwave Health compare to KORU Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNWV vs. The Competition

Sanuwave Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sanuwave Health (SNWV) Competitors

SNWV vs. FOCL, OWLT, HSAQ, INGN, and KRMD

How does Sanuwave Health compare to FocalTherics?

Do analysts recommend SNWV or FOCL?

Which has better earnings and valuation, SNWV or FOCL?

Which has more volatility and risk, SNWV or FOCL?

Is SNWV or FOCL more profitable?

Does the media refer more to SNWV or FOCL?

Do insiders and institutionals believe in SNWV or FOCL?

Summary

How does Sanuwave Health compare to Owlet?

Does the media refer more to SNWV or OWLT?

Is SNWV or OWLT more profitable?

Do analysts recommend SNWV or OWLT?

Do institutionals & insiders believe in SNWV or OWLT?

Which has more volatility & risk, SNWV or OWLT?

Which has higher valuation and earnings, SNWV or OWLT?

Summary

How does Sanuwave Health compare to Health Sciences Acquisitions Co. 2?

Which has more risk and volatility, SNWV or HSAQ?

Do analysts recommend SNWV or HSAQ?

Do institutionals and insiders believe in SNWV or HSAQ?

Does the media refer more to SNWV or HSAQ?

Is SNWV or HSAQ more profitable?

Which has preferable earnings & valuation, SNWV or HSAQ?

Summary

How does Sanuwave Health compare to Inogen?

Does the media prefer INGN or SNWV?

Is INGN or SNWV more profitable?

Which has more volatility & risk, INGN or SNWV?

Do analysts rate INGN or SNWV?

Do insiders and institutionals believe in INGN or SNWV?

Which has better earnings & valuation, INGN or SNWV?

Summary

How does Sanuwave Health compare to KORU Medical Systems?

Is KRMD or SNWV more profitable?

Which has preferable valuation and earnings, KRMD or SNWV?

Which has more volatility & risk, KRMD or SNWV?

Do institutionals & insiders have more ownership in KRMD or SNWV?

Do analysts prefer KRMD or SNWV?

Does the media favor KRMD or SNWV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNWV vs. The Competition

Sanuwave Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools